Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1

The number of patients with diabetic nephropathy (DN) is still on the rise worldwide, and this requires the development of new therapeutic strategies. Recent reports have highlighted genetic factors in the treatment of DN. Herein, we aimed to study the roles of long noncoding RNA (lncRNA) plasmacyto...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Mol Med
Autors principals: Liu, Dong-Wei, Zhang, Jia-Hui, Liu, Feng-Xun, Wang, Xu-Tong, Pan, Shao-Kang, Jiang, Deng-Ke, Zhao, Zi-Hao, Liu, Zhang-Suo
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6802617/
https://ncbi.nlm.nih.gov/pubmed/31371698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s12276-019-0259-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars